[1] |
d'Hennezel E, Bin Dhuban K, Torgerson T, et al. The immunogenetics of immune dysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome[J]. J Med Genet, 2012, 49(5): 291-302.
doi: 10.1136/jmedgenet-2012-100759
pmid: 22581967
|
[2] |
Park JH, Lee KH, Jeon B, et al. Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome: a systematic review[J]. Autoimmun Rev, 2020, 19(6): 102526.
doi: 10.1016/j.autrev.2020.102526
|
[3] |
朱琼, 袁珂, 王春林, 等. FOXP3基因突变致X连锁多内分泌腺病肠病伴免疫失调综合征二例[J]. 中华医学遗传学杂志, 2018, 35(3): 389-392.
|
[4] |
王筠, 周莉, 孙梦娇, 等. IPEX综合征1例报告并文献复习[J]. 临床儿科杂志, 2021, 39(10): 775-778.
|
[5] |
Hossain E, 田亚, 陈源, 等. IPEX综合征并发肠源性脓毒症1例并文献复习[J]. 临床荟萃, 2021, 36(5): 453-457.
|
[6] |
罗晓波. IPEX综合征及XLP-1临床与分子特点分析[D]. 重庆: 重庆医科大学, 2013.
|
[7] |
王欢, 周方, 王跃生, 等. X-连锁多内分泌腺病肠病伴免疫失调综合征1例并文献分析[J]. 长治医学院学报, 2021, 35(5): 378-380.
|
[8] |
董文芳, 曹清, 王剑, 等. X连锁多内分泌腺病肠病伴免疫失调综合征二例并文献复习[J]. 中国小儿急救医学, 2018, 25(10): 753-756.
|
[9] |
安云飞, 赵晓东, 许峰, 等. X连锁多内分泌腺病肠病伴免疫失调综合征一例基因及蛋白表达研究[J]. 中华儿科杂志, 2009, 47(11): 824-828.
|
[10] |
谭力文. 儿童X连锁多内分泌腺病肠病伴免疫失调综合征相关膜性肾病2例及文献复习[D]. 重庆: 重庆医科大学, 2021.
|
[11] |
何庭艳, 夏宇, 梁芳芳, 等. 先天性鱼鳞病样皮肤病变IPEX 1例报告并文献复习[J]. 临床儿科杂志, 2017, 35(8): 620-624.
|
[12] |
周方, 王瑞锋, 于志丹, 等. 一例晚发X-连锁多内分泌腺病肠病伴免疫失调综合征患儿的临床及遗传学研究[J]. 中华医学遗传学杂志, 2021, 38(3): 255-259.
|
[13] |
鲍文婷, 李在玲, 李军, 等. 以极早发型炎症性肠病样改变为主要特征的X连锁多内分泌腺病肠病伴免疫失调综合征一例[J]. 中华儿科杂志, 2019, 57(7): 559-561.
|
[14] |
刘丙菊, 管国涛, 赵平, 等. 以自身免疫性溶血性贫血起病的IPEX 1例[J]. 中国小儿血液与肿瘤杂志, 2020, 25(2): 104-106.
|
[15] |
王依柔, 张倩文, 丁宇, 等. 造血干细胞移植治疗以新生儿糖尿病起病的IPEX综合征:临床随访及文献复习[J]. 中华内分泌代谢杂志, 2021, 37(4): 288-292.
|
[16] |
Powell BR, Buist NR, Stenzel P. An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy[J]. J Pediatr, 1982, 100(5): 731-737.
|
[17] |
Bennett CL, Christie J, Ramsdell F, et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3[J]. Nat genet, 2001, 27(1): 20-21.
doi: 10.1038/83713
pmid: 11137993
|
[18] |
Ziegler SF. FOXP3: of mice and men[J]. Ann Rev Immunol, 2006, 24: 209-226.
doi: 10.1146/annurev.immunol.24.021605.090547
|
[19] |
Torgerson TR, Linane A, Moes N, et al. Severe food allergy as a variant of IPEX syndrome caused by a deletion in a noncoding region of the FOXP3 gene[J]. Gastroenterology, 2007, 132(5): 1705-1717.
pmid: 17484868
|
[20] |
Bacchetta R, Barzaghi F, Roncarolo MG. From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation[J]. Anna N Y Acad Sci, 2018, 1417(1): 5-22.
|
[21] |
Barzaghi F, Amaya Hernandez LC, Neven B, et al. Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: an international multicenter retrospective study[J]. J Allergy Clin Immunol, 2018, 141(3): 1036-1049.
doi: S0091-6749(17)31893-6
pmid: 29241729
|
[22] |
Duclaux-Loras R, Charbit-Henrion F, Neven B, et al. Clinical heterogeneity of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: a French multicenter retrospective study[J]. Clin Transl Gastroenterol, 2018, 9(10): 201.
|
[23] |
Hwang JL, Park SY, Ye H, et al. FOXP3 mutations causing early-onset insulin-requiring diabetes but without other features of immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome[J]. Pediatr Diabetes, 2018, 19(3): 388-392.
doi: 10.1111/pedi.12612
|
[24] |
Ge T, Wang Y, Che Y, et al. Atypical late-onset immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome with intractable diarrhea: a case report[J]. Front Pediatr, 2017, 5: 267.
doi: 10.3389/fped.2017.00267
pmid: 29312905
|
[25] |
Luo Y, Chen J, Fang Y, et al. A case of metaplastic atrophic gastritis in immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome[J]. BMC Pediatr, 2018, 18(1): 191.
doi: 10.1186/s12887-018-1169-9
pmid: 29907148
|
[26] |
Zama D, Cocchi I, Masetti R, et al. Late-onset of immunodysregulation, polyendocrinopathy, enteropathy, x-linked syndrome (IPEX) with intractable diarrhea[J]. Ital J Pediatr, 2014, 40: 68.
doi: 10.1186/s13052-014-0068-4
pmid: 25326164
|
[27] |
De Benedetti F, Insalaco A, Diamanti A, et al. Mechanistic associations of a mild phenotype of immunodysregulation, polyendocrinopathy, enteropathy, x-linked syndrome[J]. Clin Gastroenterol Hepatol, 2006, 4(5): 653-659.
doi: 10.1016/j.cgh.2005.12.014
|
[28] |
Lampasona V, Passerini L, Barzaghi F, et al. Autoantibodies to harmonin and villin are diagnostic markers in children with IPEX syndrome[J]. PLoS One, 2013, 8(11): e78664.
doi: 10.1371/journal.pone.0078664
|
[29] |
Gambineri E, Perroni L, Passerini L, et al. Clinical and molecular profile of a new series of patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome: inconsistent correlation between forkhead box protein 3 expression and disease severity[J]. J Allergy Clin Immunol, 2008, 122(6): 1105-1112.
doi: 10.1016/j.jaci.2008.09.027
pmid: 18951619
|
[30] |
Passerini L, Barzaghi F, Curto R, et al. Treatment with rapamycin can restore regulatory T-cell function in IPEX patients[J]. J Allergy Clin Immunol, 2020, 145(4): 1262-1271.
doi: S0091-6749(19)32592-8
pmid: 31874182
|
[31] |
Yamauchi T, Takasawa K, Kamiya T, et al. Hematopoietic stem cell transplantation recovers insulin deficiency in type 1 diabetes mellitus associated with IPEX syndrome[J]. Pediatr Diabetes, 2019, 20(7): 1035-1040.
doi: 10.1111/pedi.12895
pmid: 31322807
|
[32] |
Nademi Z, Slatter M, Gambineri E, et al. Single centre experience of haematopoietic SCT for patients with immunodysregulation, polyendocrinopathy, enteropathy, X-linked syndrome[J]. Bone Marrow Transplant, 2014, 49(2): 310-312.
doi: 10.1038/bmt.2013.181
|
[33] |
Wildin RS, Smyk-Pearson S, Filipovich AH. Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome[J]. J Med Genet, 2002, 39(8): 537-545.
doi: 10.1136/jmg.39.8.537
pmid: 12161590
|
[34] |
Kucuk ZY, Bleesing JJ, Marsh R, et al. A challenging undertaking: stem cell transplantation for immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome[J]. J Allergy Clin Immunol, 2016, 137(3): 953-955.
doi: 10.1016/j.jaci.2015.09.030
pmid: 26559324
|
[35] |
Burroughs LM, Nemecek ER, Torgerson TR, et al. Treosulfan-based conditioning and hematopoietic cell transplantation for nonmalignant diseases: a prospective multicenter trial[J]. Biol Blood Marrow Transplant, 2014, 20(12): 1996-2003.
doi: 10.1016/j.bbmt.2014.08.020
|
[36] |
Rao A, Kamani N, Filipovich A, et al. Successful bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning[J]. Blood, 2007, 109(1): 383-385.
doi: 10.1182/blood-2006-05-025072
pmid: 16990602
|
[37] |
Burroughs LM, Torgerson TR, Storb R, et al. Stable hematopoietic cell engraftment after low-intensity nonmyeloablative conditioning in patients with immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome[J]. J Allergy Clin Immunol, 2010, 126(5): 1000-1005.
doi: 10.1016/j.jaci.2010.05.021
pmid: 20643476
|
[38] |
Passerini L, Rossi Mel E, Sartirana C, et al. CD4+ T cells from IPEX patients convert into functional and stable regulatory T cells by FOXP3 gene transfer[J]. Sci Transl Med, 2013, 5(215): 215ra174.
|
[39] |
Passerini L, Santoni de Sio FR, Porteus MH, et al. Gene/cell therapy approaches for immune dysregulation polyendocrinopathy enteropathy X-linked syndrome[J]. Curr Gene Ther, 2014, 14(6): 422-428.
doi: 10.2174/1566523214666141001123828
pmid: 25274247
|
[40] |
Bacchetta R, Passerini L, Gambineri E, et al. Defective regulatory and effector T cell functions in patients with FOXP3 mutations[J]. J Clin Invest, 2006, 116(6): 1713-1722.
doi: 10.1172/JCI25112
pmid: 16741580
|